Cryo-Cell International, Inc. (CCEL)

USD 7.65

(-4.26%)

Market Cap (In USD)

61.67 Million

Revenue (In USD)

31.34 Million

Net Income (In USD)

-9.52 Million

Avg. Volume

3928.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4.47-9.5
PE
-
EPS
-
Beta Value
0.512
ISIN
US2288951088
CUSIP
228895108
CIK
862692
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Mr. David I. Portnoy
Employee Count
-
Website
https://www.cryo-cell.com
Ipo Date
1994-04-04
Details
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

More Stocks